Integra LifeSciences Holdings (IART) SEC Filings: History & Chart

Integra LifeSciences Holdings Corporation(IART)

Medical - Devices · Princeton, NJ

$13.07-0.22 (-1.66%)

Delayed quote: Oct 6, 2026, 10:40 AM EDT

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Princeton, NJ

4,427 employees

www.integralife.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stuart Essig

View full financials

Form	Filing Date	Accepted	Document
8-K	Oct 2, 2026	Oct 2, 2026	View filing
3	Sep 28, 2026	Sep 28, 2026	View filing
8-K	Sep 8, 2026	Sep 8, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
SC 13G	Jul 31, 2026	Jul 31, 2026	View filing
10-Q	Jul 29, 2026	Jul 29, 2026	View filing
8-K	Jul 29, 2026	Jul 29, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jun 3, 2026	Jun 3, 2026	View filing
4	Jun 3, 2026	Jun 3, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
SC 13G	May 15, 2026	May 15, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
S-8	May 8, 2026	May 8, 2026	View filing
8-K	May 8, 2026	May 8, 2026	View filing
10-Q	May 5, 2026	May 5, 2026	View filing
DEFA14A	May 5, 2026	May 5, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
8-K	Apr 15, 2026	Apr 15, 2026	View filing
DEF 14A	Apr 6, 2026	Apr 6, 2026	View filing

SEC Filings

Recent Filings